iShares Biotechnology ETF (NASDAQ:IBB) Position Lessened by Wealthcare Advisory Partners LLC

Wealthcare Advisory Partners LLC reduced its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 1.6% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,844 shares of the financial services provider’s stock after selling 180 shares during the quarter. Wealthcare Advisory Partners LLC’s holdings in iShares Biotechnology ETF were worth $1,488,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Future Financial Wealth Managment LLC bought a new position in iShares Biotechnology ETF during the 1st quarter valued at $27,000. Pacifica Partners Inc. lifted its holdings in shares of iShares Biotechnology ETF by 118.2% during the first quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock valued at $33,000 after purchasing an additional 130 shares during the last quarter. Crewe Advisors LLC boosted its position in shares of iShares Biotechnology ETF by 42.9% in the 4th quarter. Crewe Advisors LLC now owns 260 shares of the financial services provider’s stock valued at $35,000 after purchasing an additional 78 shares during the period. Northwest Financial Advisors purchased a new position in iShares Biotechnology ETF in the 4th quarter worth about $42,000. Finally, Values First Advisors Inc. acquired a new stake in iShares Biotechnology ETF during the 4th quarter worth about $43,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

iShares Biotechnology ETF stock opened at $137.91 on Friday. iShares Biotechnology ETF has a fifty-two week low of $111.83 and a fifty-two week high of $141.16. The firm’s 50 day simple moving average is $134.17 and its 200-day simple moving average is $134.74.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.